{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:19:51Z","timestamp":1787163591992,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Examine clinicopathological traits and differential diagnosis of ERMS in female reproductive system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospectively assess 13 patients\u2019 data (Jan 2018 - Jun 2024, West China Second Univsity Hospital), covering clinical, histological, immunohistochemical aspects and literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Age 2 months - 67 years (median 21), sites in cervix (5), ovaries (3), uterus (2). Non-specific symptoms. Lesions with grape-like etc. morphologies. Immunohistochemistry: the tumor cells expressed Myogenin (11\/13), Desmin (13\/13), MyoD1 (12\/13) and Myoglobin (5\/9). 4\/5 had\n                      <jats:italic>DICER1<\/jats:italic>\n                      mutations. According to the Children\u2019s Oncology Group Soft Tissue Sarcoma (COG-STS) risk classification, 11 low risk, 2 high risk. Treatments: 8 surgery + chemotherapy, 2 surgery + chemotherapy + radiotherapy, 2 surgery only. 4 died, 8 survived, 1 lost follow up. Follow-up 2 - 41 months (median 20).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      ERMS is rare, diagnosed by histology and immunohistochemistry,\n                      <jats:italic>DICER1<\/jats:italic>\n                      mutation may assist. Treatment is surgery + chemo \u00b1 radiotherapy, efficacy related to multiple factors. When ERMS is diagnosed, it is mostly in the early stage, and the treatment method is mostly surgery plus chemotherapy with or without radiotherapy. However, the treatment effect is related to factors such as staging, Intergroup Rhabdomyosarcoma Study (IRS) clinical grouping, COG-STS risk, patient age, and TP53 mutation. There is no clear guideline for the treatment of adult patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1546607","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T01:14:02Z","timestamp":1741914842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological analysis of 13 patients with embryonal rhabdomyosarcoma of the female reproductive system in the Chinese population"],"prefix":"10.3389","volume":"15","author":[{"given":"Liping","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11550","article-title":"Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution","volume":"98","author":"Ferrari","year":"2003","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24435","article-title":"COG Soft Tissue Sarcoma Committee. Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas","volume":"60","author":"Hawkins","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S44582","article-title":"Rhabdomyosarcoma in adolescent and young adult patients: current perspectives","volume":"5","author":"Egas-Bejar","year":"2014","journal-title":"Adolesc Health Med Ther"},{"key":"B5","first-page":"198","article-title":"Rhabdomyosarcoma & Embryonal Rhabdomyosarcoma]In WHO Classification of Tumours Editorial Board","author":"Parham","year":"2020","journal-title":"WHO Classification of Tumours: Soft Tissue and Bone Tumours"},{"key":"B6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/his.14449","article-title":"Evolving classification of rhabdomyosarcoma","volume":"80","author":"Agaram","year":"2022","journal-title":"Histopathology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28798","article-title":"Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Pediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe","volume":"68","author":"Rudzinski","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.07.031","article-title":"Uterine sarcomas and rare uterine mesenchymal tumors with Malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group","volume":"167","author":"Croce","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF02896576","article-title":"The intraclonal and interclonal phenotypic heterogeneity in a rhabdomyosarcoma cell line with abortive imitation of embryonic myogenesis","volume":"55","author":"Gerharz","year":"1988","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22913","article-title":"DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing","volume":"60","author":"Apellaniz-Ruiz","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/PAP.0000000000000351","article-title":"DICER1-associated tumors in the female genital tract: molecular basis, clinicopathologic features, and differential diagnosis","volume":"29","author":"Han","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.1174334","article-title":"DICER1 mutations in familial pleuropulmonary blastoma","volume":"325","author":"Hill","year":"2009","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"Foulkes","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0436-0","article-title":"Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma","volume":"33","author":"de Kock","year":"2020","journal-title":"Mod Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00804-y","article-title":"Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup","volume":"34","author":"Kommoss","year":"2021","journal-title":"Mod Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00821-x","article-title":"Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations","volume":"34","author":"Bennett","year":"2021","journal-title":"Mod Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0132-5","article-title":"DICER1 mutations are frequent in m\u00fcllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation","volume":"32","author":"Bean","year":"2019","journal-title":"Mod Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26355","article-title":"Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee","volume":"118","author":"Bisogno","year":"2012","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2020.11.003","article-title":"Management of rhabdomyosarcoma in pediatric patients","volume":"30","author":"Rogers","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655884","article-title":"Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors","volume":"12","author":"Lawrence","year":"1988","journal-title":"World J Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.sempedsurg.2011.10.007","article-title":"Update on rhabdomyosarcoma","volume":"21","author":"Dasgupta","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3768","article-title":"Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803","volume":"27","author":"Arndt","year":"2009","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21445","article-title":"Factors influencing risk-based care of the childhood cancer survivor in the 21st century","volume":"68","author":"Dixon","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/pbc.24118","article-title":"Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies","volume":"59","author":"Malempati","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijrobp.2018.08.017","article-title":"Treatment approach and outcomes in infants with localized rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group","volume":"103","author":"Bradley","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30099-2","article-title":"Soft tissue sarcomas in adolescents and young adults: a comparison with their pediatric and adult counterparts","volume":"18","author":"van der Graaf","year":"2017","journal-title":"Lancet Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2504","article-title":"Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group","volume":"8","author":"Hibbitts","year":"2019","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03060","article-title":"Genomic classification and clinical outcome in rhabdomyosarcoma: A report from an international consortium","volume":"39","author":"Shern","year":"2021","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35258","article-title":"Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram","volume":"130","author":"De Salvo","year":"2024","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10024-001-0097-z","article-title":"p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study","volume":"6","author":"Leuschner","year":"2003","journal-title":"Pediatr Dev Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3182a92d0d","article-title":"Classification of rhabdomyosarcoma and its molecular basis","volume":"20","author":"Parham","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1165::AID-CNCR21>3.0.CO;2-5","article-title":"Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group","volume":"80","author":"Lawrence","year":"1997","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200108000-00012","article-title":"Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma","volume":"234","author":"Esnaola","year":"2001","journal-title":"Ann Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10669","article-title":"Adult rhabdomyosarcoma: outcome following multimodality treatment","volume":"95","author":"Little","year":"2002","journal-title":"Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7483","article-title":"Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients","volume":"27","author":"Sultan","year":"2009","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12032-019-1282-0","article-title":"Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series","volume":"36","author":"Bergamaschi","year":"2019","journal-title":"Med Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14036","article-title":"Identification of a novel RAB3IP-HMGA2 fusion transcript in an adult head and neck rhabdomyosarcoma","volume":"28","author":"De Vita","year":"2022","journal-title":"Oral Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111564","article-title":"Deciphering the genomic landscape and pharmacological profile of uncommon entities of adult rhabdomyosarcomas","volume":"22","author":"De Vita","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ajco.13975","article-title":"Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population-based study","volume":"21","author":"How","year":"2025","journal-title":"Asia Pac J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1546607\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T01:14:04Z","timestamp":1741914844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1546607\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":39,"alternative-id":["10.3389\/fonc.2025.1546607"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1546607","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"article-number":"1546607"}}